Cargando…
Re-Defining Stem Cell-Cardiomyocyte Interactions: Focusing on the Paracrine Effector Approach
Stem cell research for treating or curing ischemic heart disease has, till date, culminated in three basic approaches: the use of induced pluripotent stem cell (iPSC) technology; reprogramming cardiac fibroblasts; and cardiovascular progenitor cell regeneration. As each approach has been shown to ha...
Autores principales: | Mahapatra, Samiksha, Martin, Dianna, Gallicano, G. Ian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Journal of Stem Cells and Regenerative Medicine
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6043659/ https://www.ncbi.nlm.nih.gov/pubmed/30018469 |
Ejemplares similares
-
Germ-line stem cells in myocardial regeneration: Secretion of cardiogenic paracrine effectors may be the future
por: Gallicano, G. Ian
Publicado: (2018) -
Cardiac inducing colonies halt fibroblast activation and induce cardiac/endothelial cells to move and expand via paracrine signaling
por: Mahapatra, Samiksha, et al.
Publicado: (2022) -
Molecular targeting of vulnerable RNA sequences in SARS CoV-2: identifying clinical feasibility
por: Gallicano, G. Ian, et al.
Publicado: (2020) -
PKG and PKC Are Down-Regulated during Cardiomyocyte Differentiation from Embryonic Stem Cells: Manipulation of These Pathways Enhances Cardiomyocyte Production
por: Mobley, Stephen, et al.
Publicado: (2010) -
Reversing Cardiac Hypertrophy at the Source Using a Cardiac Targeting Peptide Linked to miRNA106a: Targeting Genes That Cause Cardiac Hypertrophy
por: Gallicano, G. Ian, et al.
Publicado: (2022)